QUOTE AND NEWS
Motley Fool  May 4  Comment 
The dialysis services company managed to limit its red ink more effectively than investors had expected.
Motley Fool  Feb 10  Comment 
Despite a solid increase in revenue, investors in the dialysis company are disappointed with management's lackluster guidance.
Motley Fool  Feb 10  Comment 
The dialysis services company continues to see its Kidney Care investment offset any potential net income elsewhere.
Motley Fool  Nov 6  Comment 
The dialysis services company got closer to breakeven earnings and boosted its guidance on strong sales growth.





You may also be interested in articles related to NxStage Medical (NXTM):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki